img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
April 9, 2025
img
img
FatPipe, Inc.
(Nasdaq: FATN)

$4,000,000

Initial Public Offering
Sole Bookrunner

March 27, 2025
img
img
Epsium Enterprise Limited
(Nasdaq: EPSM)

$5,000,000

Initial Public Offering
Sole Bookrunner

March 26, 2025
img
img
Inspire Veterinary Partners, Inc.
(Nasdaq: IVP)

$6,000,000

Registered Direct Offering
Exclusive Placement Agent

March 4, 2025
img
img
Plus Therapeutics, Inc.
(Nasdaq: PSTV)

$15,000,000

Private Placement
Exclusive Placement Agent

February 28, 2025
img
img
LZ Technology Holdings Limited
(NASDAQ: LZMH)

$7,200,000

Initial Public Offering
Joint Bookrunner

February 21, 2025
img
img
Wellgistics Health, Inc.
(Nasdaq: WGRX)

$4,000,000

Initial Public Offering
Joint Bookrunner

February 6, 2025
img
img
Huachen AI Parking Management Technology Holding Co., Ltd
(Nasdaq: HCAI)

$6,000,000

Initial Public Offering
Joint Bookrunner

February 4, 2025
img
img
MicroVision, Inc.
(Nasdaq: MVIS)

$17,000,000

Private Placement
Co-Placement Agent

January 23, 2025
img
img
Decent Holding Inc.
(Nasdaq: DXST)

$5,000,000

Initial Public Offering
Joint Bookrunner

January 23, 2025
img
img
U.S. Energy Corp.
(Nasdaq: USEG)

$12,100,000

Public Offering
Co-Manager

January 16, 2025
img
img
Kairos Pharma, Ltd.
(NYSE: KAPA)

$3,500,000

Private Placement
Co-Placement Agent

January 14, 2025
img
img
BurTech Acquisition Corp. Merger with Blaize, Inc.
(Nasdaq: BZAI)

~$894,000,000

Business Combination
Sole Underwriter

1 2 3 … 34
Insights
  • April 9, 2025

    D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in connection with its $4.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 27, 2025

    D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 26, 2025

    D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

    Read More icon Read More icon
  • March 4, 2025

    D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

    Read More icon Read More icon
img
View All

Together, let's build meaningful value.